PMA P100024S006

Device
HER2 CISH PHARMDX KIT
Applicant
Dako Denmark A/S
PMA number
P100024
Supplement
S006
Product code
NYQ
Decision date
2014-12-29
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Approval order statement
MODIFICATION OF THE QUALITY CONTROL FOR INCOMING ALU-PNAS MATERIALS TOREDUCE HIGH BACKGROUND SIGNAL IN THE NEGATIVE CONTROLS.

Current openFDA PMA Record#

Device
HER2 CISH PHARMDX KIT
Applicant
Dako Denmark A/S
PMA number
P100024
Supplement
S006
Product code
NYQ
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Decision date
2014-12-29
Decision code
OK30
Date received
2014-12-03
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
MODIFICATION OF THE QUALITY CONTROL FOR INCOMING ALU-PNAS MATERIALS TOREDUCE HIGH BACKGROUND SIGNAL IN THE NEGATIVE CONTROLS.